By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company HCA Healthcare, Inc.

HCA Healthcare, Inc. (0J1R.L)

LSE Currency in USD
$363.27
-$5.43
-1.47%
Last Update: 16 Jul 2025, 18:13
$87.39B
Market Cap
16.15
P/E Ratio (TTM)
0.79%
Forward Dividend Yield
$216.00 - $365.00
52 Week Range

0J1R.L Stock Price Chart

Explore HCA Healthcare, Inc. interactive price chart. Choose custom timeframes to analyze 0J1R.L price movements and trends.

There is nothing to show.

0J1R.L Company Profile

Discover essential business fundamentals and corporate details for HCA Healthcare, Inc. (0J1R.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Equipment & Services

IPO Date

29 Jan 2018

Employees

226.00K

CEO

Samuel N. Hazen

Description

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

0J1R.L Financial Timeline

Browse a chronological timeline of HCA Healthcare, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 23 Apr 2026

Upcoming earnings on 22 Jan 2026

Upcoming earnings on 23 Oct 2025

Upcoming earnings on 25 Jul 2025

Revenue estimate is $18.49B.

Dividend declared on 16 Jun 2025

A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 30 Jun 2025.

Earnings released on 25 Apr 2025

EPS came in at $6.45 surpassing the estimated $5.75 by +12.17%, while revenue for the quarter reached $18.32B, missing expectations by -0.76%.

Dividend declared on 17 Mar 2025

A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 31 Mar 2025.

Earnings released on 24 Jan 2025

EPS came in at $6.22 surpassing the estimated $6.13 by +1.47%, while revenue for the quarter reached $18.29B, missing expectations by -0.09%.

Dividend declared on 13 Dec 2024

A dividend of $0.66 per share was announced, adjusted to $0.66. The dividend was paid on 27 Dec 2024.

Earnings released on 25 Oct 2024

EPS came in at $4.89 falling short of the estimated $4.96 by -1.41%, while revenue for the quarter reached $17.49B, missing expectations by -0.30%.

Dividend declared on 16 Sept 2024

A dividend of $0.66 per share was announced, adjusted to $0.66. The dividend was paid on 30 Sept 2024.

Earnings released on 23 Jul 2024

EPS came in at $5.53 surpassing the estimated $4.93 by +12.17%, while revenue for the quarter reached $17.49B, beating expectations by +2.57%.

Dividend declared on 14 Jun 2024

A dividend of $0.66 per share was announced, adjusted to $0.66. The dividend was paid on 28 Jun 2024.

Earnings released on 26 Apr 2024

EPS came in at $5.94 surpassing the estimated $5.06 by +17.39%, while revenue for the quarter reached $17.34B, beating expectations by +3.14%.

Dividend declared on 14 Mar 2024

A dividend of $0.66 per share was announced, adjusted to $0.66. The dividend was paid on 29 Mar 2024.

Earnings released on 12 Mar 2024

EPS came in at $5.93 surpassing the estimated $5.05 by +17.43%, while revenue for the quarter reached $17.30B, beating expectations by +4.79%.

Dividend declared on 13 Dec 2023

A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 28 Dec 2023.

Earnings released on 24 Oct 2023

EPS came in at $3.92 falling short of the estimated $3.98 by -1.51%, while revenue for the quarter reached $16.21B, beating expectations by +2.47%.

Dividend declared on 14 Sept 2023

A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 29 Sept 2023.

Earnings released on 27 Jul 2023

EPS came in at $4.29 surpassing the estimated $4.25 by +0.94%, while revenue for the quarter reached $15.86B, beating expectations by +1.47%.

Dividend declared on 15 Jun 2023

A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 30 Jun 2023.

Earnings released on 21 Apr 2023

EPS came in at $4.85 surpassing the estimated $3.91 by +24.04%, while revenue for the quarter reached $15.59B, beating expectations by +2.12%.

Dividend declared on 16 Mar 2023

A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 31 Mar 2023.

Earnings released on 27 Jan 2023

EPS came in at $7.28 surpassing the estimated $4.79 by +51.98%, while revenue for the quarter reached $15.50B, missing expectations by -0.85%.

Dividend declared on 13 Dec 2022

A dividend of $0.56 per share was announced, adjusted to $0.56. The dividend was paid on 28 Dec 2022.

Earnings released on 30 Sept 2022

EPS came in at $3.91 surpassing the estimated $3.88 by +0.77%, while revenue for the quarter reached $14.97B, missing expectations by -0.20%.

Dividend declared on 15 Sept 2022

A dividend of $0.56 per share was announced, adjusted to $0.56. The dividend was paid on 30 Sept 2022.

Earnings released on 30 Jun 2022

EPS came in at $3.90 surpassing the estimated $3.70 by +5.41%, while revenue for the quarter reached $14.82B, beating expectations by +0.65%.

Dividend declared on 15 Jun 2022

A dividend of $0.56 per share was announced, adjusted to $0.56. The dividend was paid on 30 Jun 2022.

Earnings released on 20 Apr 2022

EPS came in at $4.14 falling short of the estimated $4.26 by -2.82%, while revenue for the quarter reached $14.95B, beating expectations by +1.33%.

Dividend declared on 16 Mar 2022

A dividend of $0.56 per share was announced, adjusted to $0.56. The dividend was paid on 31 Mar 2022.

Earnings released on 27 Jan 2022

EPS came in at $5.75 surpassing the estimated $4.52 by +27.21%, while revenue for the quarter reached $15.06B, missing expectations by -1.87%.

Dividend declared on 13 Dec 2021

A dividend of $0.48 per share was announced, adjusted to $0.48. The dividend was paid on 29 Dec 2021.

Earnings released on 22 Oct 2021

EPS came in at $4.36, while revenue for the quarter reached $14.44B.

Earnings released on 30 Sept 2021

EPS came in at $7.00, while revenue for the quarter reached $15.28B.

Dividend declared on 15 Sept 2021

A dividend of $0.48 per share was announced, adjusted to $0.48. The dividend was paid on 30 Sept 2021.

Dividend declared on 15 Jun 2021

A dividend of $0.48 per share was announced, adjusted to $0.48. The dividend was paid on 30 Jun 2021.

Earnings released on 31 Mar 2021

EPS came in at $4.14, while revenue for the quarter reached $13.98B.

Dividend declared on 16 Mar 2021

A dividend of $0.48 per share was announced, adjusted to $0.48. The dividend was paid on 31 Mar 2021.

Earnings released on 31 Dec 2020

EPS came in at $4.13, while revenue for the quarter reached $14.29B.

Earnings released on 30 Sept 2020

EPS came in at $1.95, while revenue for the quarter reached $13.31B.

0J1R.L Stock Performance

Access detailed 0J1R.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
0J1R.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
0J1R.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More